Back to search
FDAFDA · Food and drugs·Recall number D-0570-2024

Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.

Published July 10, 2024 · Recall initiated: June 26, 2024

Summary

FDA records drug Class II recall D-0570-2024, published July 10, 2024 and initiated June 26, 2024. Recalling firm: Medisca Inc.; Status: Completed; Reported quantity: 113 bottles; Lot: Lot #s: 202323/G, 202323/H, Exp. 07/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations and Presence of Particulate Matter: Glass

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medisca Inc.
Distributor
Nationwide in the USA and Canada
Lot
Lot #s: 202323/G, 202323/H, Exp. 07/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00. recalled?

Yes. FDA published recall D-0570-2024 on July 10, 2024. Reported hazard: CGMP Deviations and Presence of Particulate Matter: Glass

What should I do if I have this product?

Voluntary: Firm initiated · Letter